News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Orphan Drug Designation for NS-089/NCNP-02 in the Treatment of Duchenne Muscular Dystrophy Granted by the European Commission
Friday, December 22, 2023NS Pharma Inc a subsidiary of Nippon Shinyaku Co Ltd has been granted orphan drug designation by the European Commission for NSNCNP on December This drug is currently in development
Ono and EVQLV Collaborate to Utilize AI-Driven Antibody Design Engine for the Development of Novel Antibody Drugs Targeting Multiple Pathways
Friday, December 22, 2023Ono Pharmaceutical Co Ltd recently announced a collaborative agreement with EVQLV INC The collaboration is focused on the development of innovative antibody drugs through the generation of novel antibodies
European Commission Revokes Generic Marketing Permissions for Dimethyl Fumarate (DMF), Including Dimethyl Fumarate Neuraxpharm
Thursday, December 21, 2023Neuraxpharm Group a leading European pharmaceutical company specializing in the treatment of central nervous system disorders has been informed by the European Commission that it will revoke all centrally granted
Rentschler Biopharma Announces a Major Client Project for Its Newly Established Facility in Milford, Massachusetts, USA
Thursday, December 21, 2023Rentschler Biopharma SE a leading global contract development and manufacturing organization specializing in biopharmaceuticals has revealed a significant development for its newly established Rentschler Biopharma Manufacturing Center
Inxmed and Escugen Have Established a Licensing Agreement to Advance the Development of Next-generation ADCS
Wednesday, December 20, 2023In a recent collaborative venture InxMed a clinicalstage biotechnology firm specializing in groundbreaking therapies for drug resistance and Escugen a clinicalstage antibodydrug conjugate
Infinimmune and Grid Therapeutics Have Joined Forces to Conduct Extensive B Cell Deep Sequencing for the Purpose of Advancing Drug Discovery in the Field of Oncology
Wednesday, December 20, 2023Infinimmune a biotechnology company specializing in novel methods for antibody drug discovery and development has recently entered into a collaboration with Grid Therapeutics a clinicalstage biotechnology
FDA Grants Orphan Drug Designation to NeuExcell's AAV Gene Therapy for Malignant Glioma
Tuesday, December 19, 2023NeuExcell Therapeutics Inc has achieved a significant milestone with the US Food and Drug Administration granting Orphan Drug Designation
HighField Biopharmaceuticals Initiates Phase 1 Clinical Trial for HFK1, a Novel Immunoliposome Targeting HER2 low and HER2+ Cancers
Tuesday, December 19, 2023HighField Biopharmaceuticals a company focused on immunooncology and utilizing lipidbased therapeutics for cancer treatment has initiated its Phase clinical trial for HFK
Charles River and Vertex Pharmaceuticals Achieve Significant Milestone in Advancing Cell Therapy Manufacturing Collaboration
Tuesday, December 19, 2023Charles River Laboratories International Inc has reached a significant milestone in its collaboration with Vertex Pharmaceuticals by obtaining regulatory approval for the production of CASGEVY
Ethris Launches Initial Human Dosing in Phase 1 Clinical Trial of ETH47 for Virus-Induced Asthma Treatment
Monday, December 18, 2023Ethris GmbH a leading biotechnology company has commenced the dosing of the first healthy participant in the Phase human study for its primary candidate ETH This candidate developed using Ethris
